4.7 Review

Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

BET proteins: Biological functions and therapeutic interventions

Jiawei Guo et al.

Summary: BET family proteins have a crucial role in interpreting histone modification and controlling gene expression, and their abnormal activation is associated with various diseases including cancer. BET bromodomain inhibitors have shown promise in treating BET-related diseases, however, drug resistance and adverse events remain major challenges in their development.

PHARMACOLOGY & THERAPEUTICS (2023)

Article Multidisciplinary Sciences

Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study

Helena A. K. Lapatto et al.

Summary: Nicotinamide riboside (NR), a precursor of nicotinamide adenine dinucleotide (NAD(+)), has shown promise in improving obesity-associated mitochondrial dysfunction and metabolic syndrome. However, short-term clinical trials have not yielded positive results. This study aimed to investigate the long-term effects of NR supplementation on mitochondrial biogenesis and metabolic health in humans. The results showed that NR improved NAD(+) metabolism, muscle mitochondrial number, myoblast differentiation, gut microbiota composition, and epigenetic control of gene expression. However, it did not improve adiposity or metabolic health.

SCIENCE ADVANCES (2023)

Article Hematology

Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results

Shinya Rai et al.

Summary: This study investigated the efficacy and safety of Tucidinostat, a novel histone deacetylase inhibitor, in patients with relapsed/refractory peripheral T-cell lymphoma (PTCL). The results showed that Tucidinostat had favorable efficacy and safety profiles, achieving partial or complete responses in patients. This indicates that Tucidinostat could be a new therapeutic option for R/R PTCL patients.

HAEMATOLOGICA (2023)

Review Biochemistry & Molecular Biology

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies

Martina Sandona et al.

Summary: Histone deacetylases (HDACs) regulate the deacetylation of proteins, affecting cellular processes. Abnormal HDAC expression or activity is associated with various pathologies, making them potential therapeutic targets. For example, HDAC inhibitors have shown positive effects in preclinical and clinical studies for Duchenne Muscular Dystrophy (DMD). Understanding the cellular functions of HDACs in dystrophic muscles provides new insights for the development of effective therapeutic approaches.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Chemistry, Medicinal

Recent progress and structural analyses of domain-selective BET inhibitors

Anand Divakaran et al.

Summary: Epigenetic mechanisms control gene expression through heritable modifications to DNA, RNA, and proteins, and the proteins responsible for these modifications have emerged as viable drug targets. Bromodomains play a key role in recognizing activating epigenetic marks, and inhibiting the bromodomain-K-ac interaction is an attractive strategy for controlling gene expression. BET proteins, containing eight bromodomains, are frequently studied for their potential anti-cancer and anti-inflammatory effects. However, on-target toxicities associated with pan-BET inhibition have hindered the development of FDA-approved drugs. This review analyzes selective inhibitors targeting the BET domain and provides insight into designing molecules with improved specificity.

MEDICINAL RESEARCH REVIEWS (2023)

Article Multidisciplinary Sciences

NAD+ repletion with niacin counteracts cancer cachexia

Marc Beltra et al.

Summary: NAD(+) loss is associated with muscle mitochondrial dysfunction in cancer hosts. Niacin supplementation improves mitochondrial metabolism and reduces muscle wasting in mouse models of cachexia. Downregulation of muscle NRK2 is correlated with metabolic abnormalities in cancer patients, highlighting the significance of NAD(+) in the pathophysiology of human cancer cachexia.

NATURE COMMUNICATIONS (2023)

Review Biochemistry & Molecular Biology

Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism

Susanna Molinari et al.

Summary: Skeletal muscle is a highly adaptable organ that adjusts its metabolism according to different functional demands. Impaired metabolic flexibility is associated with various pathologies, including sarcopenia and type 2 diabetes. Histone deacetylases (HDACs) play a crucial role in regulating skeletal muscle metabolism and have potential therapeutic implications for insulin resistance.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Article Pharmacology & Pharmacy

Systemic study of selected histone deacetylase inhibitors in cardiac complications associated with cancer cachexia

Vivek Bora et al.

Summary: This study investigated the differential effects of histone deacetylase inhibitors on cardiac complications associated with cancer cachexia. The results showed that entinostat attenuated cardiac complications, while MC1568 exacerbated these complications. The effect of sodium butyrate was inconclusive. This study provides insights for evaluating other HDACi in the management of cardiac complications in cancer cachexia.

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2022)

Article Geriatrics & Gerontology

Epigenome-wide association study of sarcopenia: findings from the Hertfordshire Sarcopenia Study (HSS)

Elie Antoun et al.

Summary: This study found that differences in muscle methylome are associated with sarcopenia and individual measures of muscle mass, strength, and function in older individuals, suggesting that changes in epigenetic regulation of genes may contribute to impaired muscle function in later life.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Review Oncology

Annual Review of Cancer Biology Targeting BET Bromodomains in Cancer

Patrick Trojer

Summary: BET bromodomain inhibition plays an important role in cancer therapy by targeting the transcriptional process. Although initial clinical data raised doubts about the benefits of BET inhibitors, recent studies have shown potential clinical applications in certain patients.

ANNUAL REVIEW OF CANCER BIOLOGY (2022)

Review Biochemistry & Molecular Biology

BET bromodomain inhibitors

Martin P. Schwalm et al.

Summary: Lysine acetylation creates docking sites for epigenetic reader domains of BET bromodomain proteins, which are important regulators of linage specific gene transcription. The development of potent and selective inhibitors has facilitated mechanistic studies in disease models and translation into clinical practice. Advances in pan-BET inhibitors have led to second generation inhibitors with improved selectivity, as well as highly potent bifunctional and dual inhibitors, expanding the toolbox for research on acetylation dependent transcription, BET-associated diseases, and epigenetic reader domains.

CURRENT OPINION IN CHEMICAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Role of Glucocorticoid Signaling and HDAC4 Activation in Diaphragm and Gastrocnemius Proteolytic Activity in Septic Rats

Alvaro Moreno-Ruperez et al.

Summary: This study aimed to investigate the mechanism behind the difference in muscle wasting caused by sepsis. The researchers found that local inflammation, IGF-1, glucocorticoid response, and HDAC4-myogenin activation all played important roles in this process.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cell & Tissue Engineering

Metabolic Remodeling Impacts the Epigenetic Landscape of Dental Mesenchymal Stem Cells

Haiyun Luo et al.

Summary: This review discusses the impact of metabolic fluctuations on epigenetic modifications in the oral and maxillofacial regions, summarizes the interaction between metabolite substrates and canonical epigenetic events in dental mesenchymal stem cells, and highlights the important role of the coordination between metabolic pathways and epigenetic events in cellular processes.

STEM CELLS INTERNATIONAL (2022)

Article Oncology

Phase III MANIFEST-2: pelabresib plus ruxolitinib vs placebo plus ruxolitinib in JAK inhibitor treatment-naive myelofibrosis

Claire N. Harrison et al.

Summary: Myelofibrosis (MF) is a rare type of blood cancer that leads to scarring in the bone marrow and a lack of healthy blood cell production. The current standard treatment, ruxolitinib, has limited efficacy in improving symptoms long term. Pelabresib is a new drug being developed for MF. This article describes the design of the ongoing MANIFEST-2 study, which is evaluating the effectiveness and safety of pelabresib and ruxolitinib compared to placebo and ruxolitinib in MF patients.

FUTURE ONCOLOGY (2022)

Review Cell Biology

Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia

Laura Yedigaryan et al.

Summary: Cachexia and sarcopenia are significant conditions involving muscle loss, which can lead to mortality and disability. MicroRNAs play a key role in the development of muscle wasting in both cachexia and sarcopenia. Understanding the epigenetic mechanisms related to muscle loss in these conditions can help identify potential therapeutic interventions.
Review Geriatrics & Gerontology

Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review

Lara Vilar Fernandes et al.

Summary: Compared to EWGSOP1, the prevalence of sarcopenia in older adults decreased when diagnosed according to EWGSOP2. Based on limited evidence, EWGSOP2 seems to be worse for predicting unfavorable outcomes compared with EWGSOP1.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Review Biochemistry & Molecular Biology

Cancer cachexia: molecular mechanism and pharmacological management

Yonghua Li et al.

Summary: Cancer cachexia is a multifactorial and complex symptom that often occurs in malignant tumors, characterized by weight loss, poor quality of life and shorter survival. Research has shown that the pathogenic mechanism of cancer cachexia involves various molecular substrates and signaling pathways, highlighting the need for further exploration in the treatment of this condition.

BIOCHEMICAL JOURNAL (2021)

Article Biochemistry & Molecular Biology

BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection

Richard J. Mills et al.

Summary: Cardiac injury and dysfunction in COVID-19 patients increase mortality risk. An inflammatory cytokine-storm can induce diastolic dysfunction, but BET inhibitors show promise in preventing cardiac damage and dysfunction induced by the virus.
Review Medicine, Research & Experimental

Role of myokines and osteokines in cancer cachexia

Fabrizio Pin et al.

Summary: Cancer-induced muscle wasting, or cachexia, is a common and debilitating feature in cancer patients, leading to musculoskeletal alterations. Communication between muscle and bone through cell factors is important in this process, with myokines and osteokines playing key roles in cancer-induced cachexia.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Review Cell Biology

Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration

Marc Beltra et al.

Summary: Cancer cachexia is a frequently neglected syndrome with complex pathogenesis impacting patients' quality of life, and no effective therapeutic approach has been identified yet.
Review Medicine, Research & Experimental

The mechanism by which noncoding RNAs regulate muscle wasting in cancer cachexia

Xueer Zhou et al.

Summary: Cancer cachexia is a complex metabolic syndrome that accelerates muscle wasting in cancer patients, with a lack of effective treatments. Studies have shown that noncoding RNAs play a critical role in cachectic muscles and may serve as potential therapeutic targets.

PRECISION CLINICAL MEDICINE (2021)

Review Cell Biology

Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Kunal Nepali et al.

Summary: Research in epigenetic drug discovery has advanced significantly, with efforts focused on developing treatment strategies and utilizing emerging technologies like PROTACS and CRISPR/Cas9. Multi-targeting scaffold assemblies have been proposed as potential alternatives to combination therapy.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Review Biochemistry & Molecular Biology

The BET family in immunity and disease

Nian Wang et al.

Summary: The BET family plays a crucial role in regulating the transcription of genes associated with inflammation and immunity by recognizing acetylated histones and recruiting transcription factors and elongation complexes. Manipulating the BET family holds promise as a new treatment approach for disease.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, Research & Experimental

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

Sophia G. Liva et al.

EMBO MOLECULAR MEDICINE (2020)

Article Geriatrics & Gerontology

Aging alters acetylation status in skeletal and cardiac muscles

Dongwook Yeo et al.

GEROSCIENCE (2020)

Article Immunology

SIRT1-NOX4 signaling axis regulates cancer cachexia

Aneesha Dasgupta et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Genetics & Heredity

The evolving metabolic landscape of chromatin biology and epigenetics

Ziwei Dai et al.

NATURE REVIEWS GENETICS (2020)

Article Multidisciplinary Sciences

BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy

Marco Segatto et al.

NATURE COMMUNICATIONS (2020)

Review Cell Biology

Bone and Muscle Crosstalk in Aging

Chen He et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Muscle-bone crosstalk and potential therapies for sarco-osteoporosis

GuoBin Li et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Review Medicine, Research & Experimental

From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs

Rebecca L. McIntyre et al.

EMBO MOLECULAR MEDICINE (2019)

Article Medicine, General & Internal

Muscular dystrophies

Eugenio Mercuri et al.

LANCET (2019)

Review Biochemistry & Molecular Biology

Bromodomain biology and drug discovery

Nilesh Zaware et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)

Article Geriatrics & Gerontology

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition

Nicolaas E. P. Deutz et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2019)

Review Cell Biology

Functions and mechanisms of non-histone protein acetylation

Takeo Narita et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Article Multidisciplinary Sciences

Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities

Eugenia Migliavacca et al.

NATURE COMMUNICATIONS (2019)

Review Biochemistry & Molecular Biology

AMPK in skeletal muscle function and metabolism

Rasmus Kjobsted et al.

FASEB JOURNAL (2018)

Article Neurosciences

Autophagy and mitophagy flux in young and aged skeletal muscle following chronic contractile activity

Heather N. Carter et al.

JOURNAL OF PHYSIOLOGY-LONDON (2018)

Article Geriatrics & Gerontology

miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk

Aiqing Zhang et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2018)

Article Multidisciplinary Sciences

Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer

Jingyi Liu et al.

NATURE COMMUNICATIONS (2018)

Review Pharmacology & Pharmacy

Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review

Lluis Campins et al.

PHARMACOLOGY (2017)

Article Multidisciplinary Sciences

Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival

Marco Segatto et al.

NATURE COMMUNICATIONS (2017)

Article Geriatrics & Gerontology

Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice

Jacob L. Brown et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2017)

Article Multidisciplinary Sciences

The long noncoding RNA SPRIGHTLY acts as an intranuclear organizing hub for pre-mRNA molecules

Bongyong Lee et al.

SCIENCE ADVANCES (2017)

Article Multidisciplinary Sciences

BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis

Thomas C. Roberts et al.

SCIENTIFIC REPORTS (2017)

Article Endocrinology & Metabolism

Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome

Seol-Hee Kang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2017)

Article Nutrition & Dietetics

One-carbon metabolism and epigenetics: understanding the specificity

Samantha J. Mentch et al.

DIET, SULFUR AMINO ACIDS, AND HEALTH SPAN (2016)

Article Cell Biology

Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia

Rulin Sun et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)

Article Biochemistry & Molecular Biology

HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells

Mingming Fang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2016)

Review Cell Biology

Mechanisms of metabolic dysfunction in cancer-associated cachexia

Michele Petruzzelli et al.

GENES & DEVELOPMENT (2016)

Review Biochemistry & Molecular Biology

Regenerative decline of stem cells in sarcopenia

Pedro Sousa-Victor et al.

MOLECULAR ASPECTS OF MEDICINE (2016)

Editorial Material Multidisciplinary Sciences

Bet on drug resistance

Jeff Settleman

NATURE (2016)

Article Multidisciplinary Sciences

Autophagy maintains stemness by preventing senescence

Laura Garcia-Prat et al.

NATURE (2016)

Article Clinical Neurology

Histological effects of givinostat in boys with Duchenne muscular dystrophy

Paolo Bettica et al.

NEUROMUSCULAR DISORDERS (2016)

Review Cell Biology

Impaired regeneration: A role for the muscle microenvironment in cancer cachexia

Erin E. Talbert et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2016)

Article Physiology

Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways

Rafael Barreto et al.

FRONTIERS IN PHYSIOLOGY (2016)

Review Cell Biology

Acetyl Coenzyme A: A Central Metabolite and Second Messenger

Federico Pietrocola et al.

CELL METABOLISM (2015)

Article Cardiac & Cardiovascular Systems

Angiotensin II Induces Skeletal Muscle Atrophy by Activating TFEB-Mediated MuRF1 Expression

Philipp Du Bois et al.

CIRCULATION RESEARCH (2015)

Article Pharmacology & Pharmacy

Cachexia and sarcopenia: mechanisms and potential targets for intervention

Josep M. Argiles et al.

CURRENT OPINION IN PHARMACOLOGY (2015)

Article Physiology

Trichostatin A, a histone deacetylase inhibitor, modulates unloaded-induced skeletal muscle atrophy

Sylvie Dupre-Aucouturier et al.

JOURNAL OF APPLIED PHYSIOLOGY (2015)

Article Oncology

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

Yu-Chou Tseng et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Review Biotechnology & Applied Microbiology

Muscle wasting in disease: molecular mechanisms and promising therapies

Shenhav Cohen et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Review Physiology

HISTONE DEACETYLASES IN BONE DEVELOPMENT AND SKELETAL DISORDERS

Elizabeth W. Bradley et al.

PHYSIOLOGICAL REVIEWS (2015)

Article Oncology

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

Yu-Chou Tseng et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Biochemistry & Molecular Biology

Histone Deacetylase 6 Is a FoxO Transcription Factor-dependent Effector in Skeletal Muscle Atrophy

Francesca Ratti et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Cell Biology

Mitochondrial energetics is impaired in vivo in aged skeletal muscle

Gilles Gouspillou et al.

AGING CELL (2014)

Article Biochemistry & Molecular Biology

NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis

Jonathan D. Brown et al.

MOLECULAR CELL (2014)

Article Biochemistry & Molecular Biology

Brd4 activates P-TEFb for RNA polymerase II CTD phosphorylation

Friederike Itzen et al.

NUCLEIC ACIDS RESEARCH (2014)

Article Multidisciplinary Sciences

Negative Auto-Regulation of Myostatin Expression is Mediated by Smad3 and MicroRNA-27

Craig McFarlane et al.

PLOS ONE (2014)

Article Cell Biology

Writers and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition

Ronen Marmorstein et al.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2014)

Article Biochemistry & Molecular Biology

Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers

Jakob Loven et al.

Review Biochemistry & Molecular Biology

Mitochondrial dysfunction and sarcopenia of aging: From signaling pathways to clinical trials

Emanuele Marzetti et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)

Article Medicine, Research & Experimental

NF-κB-mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia

Wei A. He et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Pediatrics

HDAC inhibitors in kidney development and disease

Lauren L. Brilli et al.

PEDIATRIC NEPHROLOGY (2013)

Article Biochemistry & Molecular Biology

Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family

Panagis Filippakopoulos et al.

Review Cell Biology

Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways

Kenneth C. H. Fearon et al.

CELL METABOLISM (2012)

Article Biochemistry & Molecular Biology

NCoR1 Is a Conserved Physiological Modulator of Muscle Mass and Oxidative Function

Hiroyasu Yamamoto et al.

Article Biochemistry & Molecular Biology

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

Jake E. Delmore et al.

Article Geriatrics & Gerontology

Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ Between Young and Sarcopenic Elderly Men

A. Ratkevicius et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2011)

Article Endocrinology & Metabolism

Myostatin Induces Degradation of Sarcomeric Proteins through a Smad3 Signaling Mechanism During Skeletal Muscle Wasting

Sudarsanareddy Lokireddy et al.

MOLECULAR ENDOCRINOLOGY (2011)

Article Multidisciplinary Sciences

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber et al.

NATURE (2011)

Article Geriatrics & Gerontology

Sarcopenia: European consensus on definition and diagnosis

Alfonso J. Cruz-Jentoft et al.

AGE AND AGEING (2010)

Article Biochemistry & Molecular Biology

Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia

Margaret E. Benny Klimek et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Article Biochemistry & Molecular Biology

Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases

Viviana Moresi et al.

Article Geriatrics & Gerontology

Skeletal muscle autophagy and apoptosis during aging: Effects of calorie restriction and life-long exercise

Stephanie Eva Wohlgemuth et al.

EXPERIMENTAL GERONTOLOGY (2010)

Article Biochemistry & Molecular Biology

Muscle Wasting in Aged, Sarcopenic Rats Is Associated with Enhanced Activity of the Ubiquitin Proteasome Pathway

Mikael Altun et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Cell Biology

Smad2 and 3 transcription factors control muscle mass in adulthood

Roberta Sartori et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)

Review Biochemistry & Molecular Biology

PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure

Carles Canto et al.

CURRENT OPINION IN LIPIDOLOGY (2009)

Review Oncology

Vorinostat in solid and hematologic malignancies

David Siegel et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)

Article Geriatrics & Gerontology

Higher Inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength

Laura A. Schaap et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2009)

Article Biochemistry & Molecular Biology

Brd4 Coactivates Transcriptional Activation of NF-κB via Specific Binding to Acetylated RelA

Bo Huang et al.

MOLECULAR AND CELLULAR BIOLOGY (2009)

Article Multidisciplinary Sciences

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

Carles Canto et al.

NATURE (2009)

Review Genetics & Heredity

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

Michael Haberland et al.

NATURE REVIEWS GENETICS (2009)

Article Biochemistry & Molecular Biology

An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C-elegans

Eric L. Greer et al.

CURRENT BIOLOGY (2007)

Article Biotechnology & Applied Microbiology

Antagonism of myostatin enhances muscle regeneration during sarcpenia

Victoria Siriett et al.

MOLECULAR THERAPY (2007)

Article Multidisciplinary Sciences

AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α

Sibylle Jaeger et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Biochemistry & Molecular Biology

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α

Zachary Gerhart-Hines et al.

EMBO JOURNAL (2007)

Review Biochemistry & Molecular Biology

Discovery and development of SAHA as an anticancer agent

P. A. Marks

ONCOGENE (2007)

Article Multidisciplinary Sciences

PGC-1α a protects skeletal muscle from atrophy by suppressing Fox03 action and atrophy-specific gene transcription

Marco Sandri et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Biochemistry & Molecular Biology

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors

G. C. Minetti et al.

NATURE MEDICINE (2006)

Article Cell Biology

Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior muscle

Stephan Clavel et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2006)

Article Geriatrics & Gerontology

Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle

Erik Edstrom et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2006)

Article Biochemistry & Molecular Biology

SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α

S Nemoto et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle

D Cuthbertson et al.

FASEB JOURNAL (2004)

Article Cell Biology

Gene expression profile of aging in human muscle

S Welle et al.

PHYSIOLOGICAL GENOMICS (2003)

Article Multidisciplinary Sciences

Stage-specific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases

S Iezzi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Multidisciplinary Sciences

Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy

MD Gomes et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Multidisciplinary Sciences

Identification of ubiquitin ligases required for skeletal muscle atrophy

SC Bodine et al.

SCIENCE (2001)

Article Biochemistry & Molecular Biology

A dynamic role for HDAC7 in MEF2-mediated muscle differentiation

U Dressel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Neurosciences

Oxidative capacity and ageing in human muscle

KE Conley et al.

JOURNAL OF PHYSIOLOGY-LONDON (2000)

Article Multidisciplinary Sciences

Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases

JR Lu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)